Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
4D pharma PLC Sponsored ADR (LBPS) Consolidated Net Income/Loss data is not available for the most recently reported fiscal quarter, ending 2021-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Consolidated Net Income/Loss |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$41.52M |
|
$5.56M |
|
$25.08M |
|
$66.60M |
|
$9.83M |
|
$1.31M |
|
$1.33M |
|
$11.16M |
|
$55.44M |
|
$36.18M |
|
$55.44M |
|
22.54M |
|
| Cash Flow Statement Financials | |
$-16.05M |
|
$-0.16M |
|
$32.94M |
|
$12.27M |
|
$29.00M |
|
$16.73M |
|
$61.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|